Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJROBP.2003.10.056PMID 15093901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy.

  2002cited by this paper
• Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.

  2002cited by this paper
• Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer

  2002cited by this paper
• Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.

  2002cited by this paper
• Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients.

  2002cited by this paper
• RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck.

  2001cited by this paper
• Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

  2001cited by this paper
• Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.

  2000cited by this paper
• Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial

  2000cited by this paper
• A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.

  2000cited by this paper
• Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol.

  1999cited by this paper
• Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.

  1998cited by this paper
• Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer.

  1998cited by this paper
• Réirradiation hyperfractionnée après chirurgie de rattrapage de carcinomes cervicaux-faciaux. Résultat d'une étude pilote de 14 patients

  1997cited by this paper
• [Hyperfractionated reirradiation after salvage surgery in cervico-facial carcinoma. Result of a pilot study in 14 patients].

  1997cited by this paper
• Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: an experimental study.

  1996cited by this paper
• Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.

  1996cited by this paper
• Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx.

  1995cited by this paper
• Salvage Laryngectomy for Unsuccessful Larynx Preservation Therapy

  1995cited by this paper
• High-dose reirradiation of head and neck cancer with curative intent

  1994cited by this paper
• High-dose reirradiation of head and neck cancer with curative intent.

  1994cited by this paper
• Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.

  1993cited by this paper
• Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034.

  1992cited by this paper
• Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.

  1992cited by this paper
• Postoperative irradiation for squamous cell carcinoma of the head and neck.

  1990cited by this paper
• Reirradiation of recurrent head and neck cancers

  1987cited by this paper
• Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications.

  1987cited by this paper
• Tolerance of surgery after radical radiotherapy of carcinoma of the oropharynx

  1978cited by this paper

• Global Incidence, Mortality, and Risk Factors of Stroke in Multi‐Modality Head and Neck Cancer Treatment—A Systematic Review and Meta‐Analysis

  2025cites this paper
• Vascular events in patients with head and neck cancer: A systematic review and meta‐analysis

  2024cites this paper
• Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

  2022cites this paper
• Managing Recurrent Metastatic Head and Neck Cancer.

  2021cites this paper
• AHNS series: Do you know your guidelines? Guideline recommendations for recurrent and persistent head and neck cancer after primary treatment

  2018cites this paper
• Facteurs pronostiques de la ré-irradiation des cancers des voies aérodigestives supérieures : revue de la littérature

  2017cites this paper
• [Prognostic factors for head and neck cancer reirradiation: A systematic review].

  2017influential citation
• Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.

  2017cites this paper
• What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria.

  2017cites this paper
• Function and regulation of TRPM7, as well as intracellular magnesium content, are altered in cells expressing ΔF508-CFTR and G551D-CFTR

  2016cites this paper
• Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic

  2016cites this paper
• A Retrospective Study of Reirradiation for Patients with Locoregional Recurrent Head and Neck Cancer: A Single-Institution Experience

  2016cites this paper
• Functional and pathological relevance of HERC family proteins: a decade later

  2016cites this paper
• Head and Neck Tumors: Viewpoint—Fractionated Radiation Therapy and Chemotherapy

  2015cites this paper
• Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study

  2015cites this paper
• Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes

  2015cites this paper
• Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate

  2015cites this paper
• Role of reradiation in head and neck cancer from limits to option

  2015cites this paper
• Reirradiation and stereotactic body radiotherapy for recurrent or second primary squamous cell carcinoma of the head and neck

  2015cites this paper
• Effect of Amifostine in Head and Neck Cancer Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials

  2014cites this paper
• Metastatic carcinoma to percutaneous endoscopic gastrostomy tube sites. A report of five cases.

  2014cites this paper
• Adjuvant stereotactic body radiotherapy ± cetuximab following salvage surgery in previously irradiated head and neck cancer

  2014cites this paper
• Patterns of failure after salvage re-irradiation for recurrent head and neck cancer: implications for field design and consolidation therapy

  2014cites this paper
• Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.

  2012cites this paper
• Risk of carotid blowout after reirradiation of the head and neck: a systematic review.

  2012cites this paper
• Retreatment of recurrent head and neck cancer in a previously irradiated field.

  2012cites this paper
• Reirradiation for recurrent head and neck carcinoma.

  2012cites this paper
• Reirradiation for recurrent head and neck cancer

  2012cites this paper
• Second Course of Radiation for New Primary Head-and-Neck Cancer: Population-Based Study of Survival

  2011cites this paper
• Salvage Therapy in Head and Neck Cancer Patients

  2011cites this paper
• [Reirradiation for recurrent or second primary head and neck cancers].

  2011cites this paper
• Reirradiation in head and neck cancers

  2011cites this paper
• Lymphedema in patients with head and neck cancer.

  2011cites this paper
• IMRT Reirradiation with Concurrent Cetuximab Immunotherapy in Recurrent Head and Neck Cancer

  2010cites this paper
• Internal structures , Lymphedema in Patients With Head and Neck Cancer

  2010cites this paper
• Outcome after Re-Irradiation of Head and Neck Cancer Patients

  2010cites this paper
• Chemoreirradiation for recurrent salivary gland malignancies.

  2010cites this paper
• Head and Neck Cancer

  2010cites this paper
• Normal Tissue Tolerance to Reirradiation

  2010cites this paper
• Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy

  2010cites this paper
• Contemporary management of oropharyngeal cancer: anatomy and physiology of the oropharynx.

  2009cites this paper
• IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

  2009cites this paper
• Cancer of the head and neck is the sixth most common cancer worldwide.

  2009cites this paper
• Recurrent salivary gland carcinomas treated by surgery with or without intraoperative radiation therapy

  2008cites this paper
• Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

  2008cites this paper
• Three-Dimensional Conformal or Stereotactic Reirradiation of Recurrent, Metastatic or New Primary Tumors

  2008influential citation
• Re-irradiation of Head and Neck Carcinoma

  2008cites this paper
• [Salvage surgery fot advanced head and neck cancer].

  2008cites this paper
• Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.

  2008cites this paper
• Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.

  2008cites this paper
• Outcomes following reirradiation of patients with head and neck cancer

  2008cites this paper
• Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience.

  2007cites this paper
• Reirradiation in squamous cell head and neck cancer: recent developments and future directions

  2007cites this paper
• Preliminary results of pre-radiation neck dissection in head and neck cancer patients undergoing organ preservation treatment

  2007cites this paper
• Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.

  2007cites this paper
• Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.

  2007cites this paper
• Current surgical treatment of squamous cell carcinoma of the head and neck.

  2007cites this paper
• Salvage re-irradiation for recurrent head and neck cancer.

  2007cites this paper
• Cytoprotective agents used in the treatment of patients with cancer.

  2007cites this paper
• Selected topics in head and neck cancer

  2006cites this paper
• Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.

  2006cites this paper
• Re-irradiation in the management of isolated neck recurrences: current status and recommendations.

  2006cites this paper
• Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

  2006cites this paper
• Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

  2006cites this paper
• Commentary: The Pharmacological Antioxidant Amifostine—Implications of Recent Research for Integrative Cancer Care

  2005cites this paper
• Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

  2005cites this paper
• Expression of bone morphogenic protein 2/4, transforming growth factor-beta1, and bone matrix protein expression in healing area between vascular tibia grafts and irradiated bone-experimental model of osteonecrosis.

  2005cites this paper
• Review of current treatment practices for carcinoma of the head and neck

  2005cites this paper